Literature DB >> 23948918

Characterization of mitochondrial dysfunction in the 7PA2 cell model of Alzheimer's disease.

Nina Krako1, Maria Chiara Magnifico, Marzia Arese, Giovanni Meli, Elena Forte, Agnese Lecci, Annalisa Manca, Alessandro Giuffrè, Daniela Mastronicola, Paolo Sarti, Antonino Cattaneo.   

Abstract

The 7WD4 and 7PA2 cell lines, widely used as cellular models for Alzheimer's disease (AD), have been used to investigate the effects of amyloid-β protein precursor overexpression and amyloid-β (Aβ) oligomer accumulation on mitochondrial function. Under standard culture conditions, both cell lines, compared to Chinese hamster ovary (CHO) control cells, displayed an ~5% decrease of O2 respiration as sustained by endogenous substrates. Functional impairment of the respiratory chain was found distributed among the protein complexes, though more evident at the level of complex I and complex IV. Measurements of ATP showed that its synthesis by oxidative phosphorylation is decreased in 7WD4 and 7PA2 cells by ~25%, this loss being partly compensated by glycolysis (Warburg effect). Compensation proved to be more efficient in 7WD4 than in 7PA2 cells, the latter cell line displaying the highest reactive oxygen species production. The strongest deficit was observed in mitochondrial membrane potential that is almost 40% and 60% lower in 7WD4 and 7PA2 cells, respectively, in comparison to CHO controls. All functional parameters point to a severe bioenergetic impairment of the AD cells, with the extent of mitochondrial dysfunction being correlated to the accumulation of Aβ peptides and oligomers.

Entities:  

Keywords:  Alzheimer's disease; amyloid-β oligomers; bioenergetics; mitochondrial dysfunction

Mesh:

Substances:

Year:  2013        PMID: 23948918     DOI: 10.3233/JAD-130728

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  12 in total

Review 1.  The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.

Authors:  Margrethe A Olesen; Francisca Villavicencio-Tejo; Rodrigo A Quintanilla
Journal:  Transl Neurodegener       Date:  2022-07-04       Impact factor: 9.883

2.  Conformational targeting of intracellular Aβ oligomers demonstrates their pathological oligomerization inside the endoplasmic reticulum.

Authors:  Giovanni Meli; Agnese Lecci; Annalisa Manca; Nina Krako; Valentina Albertini; Luisa Benussi; Roberta Ghidoni; Antonino Cattaneo
Journal:  Nat Commun       Date:  2014-05-27       Impact factor: 14.919

3.  Upregulation of glycolytic enzymes, mitochondrial dysfunction and increased cytotoxicity in glial cells treated with Alzheimer's disease plasma.

Authors:  Tharusha Jayasena; Anne Poljak; Nady Braidy; George Smythe; Mark Raftery; Mark Hill; Henry Brodaty; Julian Trollor; Nicole Kochan; Perminder Sachdev
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

4.  Metabolic Characterization of Intact Cells Reveals Intracellular Amyloid Beta but Not Its Precursor Protein to Reduce Mitochondrial Respiration.

Authors:  Patrick M Schaefer; Bjoern von Einem; Paul Walther; Enrico Calzia; Christine A F von Arnim
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

5.  Mitochondrial hyperpolarization in iPSC-derived neurons from patients of FTDP-17 with 10+16 MAPT mutation leads to oxidative stress and neurodegeneration.

Authors:  Noemí Esteras; Jonathan D Rohrer; John Hardy; Selina Wray; Andrey Y Abramov
Journal:  Redox Biol       Date:  2017-03-10       Impact factor: 11.799

6.  Nonylphenol and Octylphenol Differently Affect Cell Redox Balance by Modulating the Nitric Oxide Signaling.

Authors:  Maria Chiara Magnifico; Marla Xhani; Milica Popov; Luciano Saso; Paolo Sarti; Marzia Arese
Journal:  Oxid Med Cell Longev       Date:  2018-04-02       Impact factor: 6.543

Review 7.  The Role of Mitochondrial Dysfunction in the Progression of Alzheimer's Disease.

Authors:  Claus Desler; Meryl S Lillenes; Tone Tønjum; Lene Juel Rasmussen
Journal:  Curr Med Chem       Date:  2018       Impact factor: 4.530

Review 8.  Mitochondrial dysfunction: different routes to Alzheimer's disease therapy.

Authors:  Pasquale Picone; Domenico Nuzzo; Luca Caruana; Valeria Scafidi; Marta Di Carlo
Journal:  Oxid Med Cell Longev       Date:  2014-08-20       Impact factor: 6.543

Review 9.  Oncostatic-Cytoprotective Effect of Melatonin and Other Bioactive Molecules: A Common Target in Mitochondrial Respiration.

Authors:  Nicola Pacini; Fabio Borziani
Journal:  Int J Mol Sci       Date:  2016-03-07       Impact factor: 5.923

10.  Amyloid precursor protein drives down-regulation of mitochondrial oxidative phosphorylation independent of amyloid beta.

Authors:  M Isabel G Lopez Sanchez; Hayley S Waugh; Andrew Tsatsanis; Bruce X Wong; Jonathan G Crowston; James A Duce; Ian A Trounce
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.